Chemical Formula: C21H21NO4

Chemical Formula C21H21NO4

Found 54 metabolite its formula value is C21H21NO4

   

Zindoxifene

Zindoxifene

C21H21NO4 (351.14705060000006)


C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist C1892 - Chemopreventive Agent

   
   
   

(-)-phyllosteminine|Phyllosteminine

(-)-phyllosteminine|Phyllosteminine

C21H21NO4 (351.14705060000006)


   

(+)-(6aR,7R)-N-butyrylnorushinsunine

(+)-(6aR,7R)-N-butyrylnorushinsunine

C21H21NO4 (351.14705060000006)


   
   

O-Demethylbuchenavianine

O-Demethylbuchenavianine

C21H21NO4 (351.14705060000006)


A piperidine alkaloid that consists of 5,7-dihydroxyflavone attached to a 1-methylpiperindin-2-yl moiety at position 8. It is a flavonoid alkaloid isolated from Buchenavia capitata, and has been shown to exhibit anti-HIV activity.

   
   
   
   

RCS-4 N-(5-carboxypentyl) metabolite

RCS-4 N-(5-carboxypentyl) metabolite

C21H21NO4 (351.14705060000006)


   
   
   
   
   

(-)-(1R,3S)-N-Fmoc-3-Aminocyclopentanecarboxylic acid

(-)-(1R,3S)-N-Fmoc-3-Aminocyclopentanecarboxylic acid

C21H21NO4 (351.14705060000006)


   

(R)-N-Fmoc-2-(2-propylenyl)alanine

(R)-N-Fmoc-2-(2-propylenyl)alanine

C21H21NO4 (351.14705060000006)


   

3-(4-METHOXYPHENYL)-5-ISOXAZOLYL]METHANAMINE

3-(4-METHOXYPHENYL)-5-ISOXAZOLYL]METHANAMINE

C21H21NO4 (351.14705060000006)


   

2-CHLORO-5-METHYL-1,4-BENZOQUINONE

2-CHLORO-5-METHYL-1,4-BENZOQUINONE

C21H21NO4 (351.14705060000006)


   

(+)-(1S,3R)-N-Fmoc-3-Aminocyclopentanecarboxylic acid

(+)-(1S,3R)-N-Fmoc-3-Aminocyclopentanecarboxylic acid

C21H21NO4 (351.14705060000006)


   
   
   

2-[[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]METHYL]PHTHALIMIDE

2-[[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]METHYL]PHTHALIMIDE

C21H21NO4 (351.14705060000006)


   
   
   

tert-Butyl 6-(benzyloxy)-3-formyl-1H-indole-1-carboxylate

tert-Butyl 6-(benzyloxy)-3-formyl-1H-indole-1-carboxylate

C21H21NO4 (351.14705060000006)


   

(1R,2R)-2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)CYCLOPENTANECARBOXYLIC ACID

(1R,2R)-2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)CYCLOPENTANECARBOXYLIC ACID

C21H21NO4 (351.14705060000006)


   
   
   

4-(5-(4-(Pentyloxy)phenyl)isoxazol-3-yl)benzoic acid

4-(5-(4-(Pentyloxy)phenyl)isoxazol-3-yl)benzoic acid

C21H21NO4 (351.14705060000006)


   
   
   
   
   
   

N-Fmoc-1-amino-1-cyclopentanecarboxylic acid

N-Fmoc-1-amino-1-cyclopentanecarboxylic acid

C21H21NO4 (351.14705060000006)


   
   
   

[(3Z)-2-oxo-3-(1,3,3-trimethylindol-2-ylidene)propyl] 4-hydroxybenzoate

[(3Z)-2-oxo-3-(1,3,3-trimethylindol-2-ylidene)propyl] 4-hydroxybenzoate

C21H21NO4 (351.14705060000006)


   

Methyl 4-(5-{[(2-hydroxy-2-phenylethyl)amino]methyl}furan-2-yl)benzoate

Methyl 4-(5-{[(2-hydroxy-2-phenylethyl)amino]methyl}furan-2-yl)benzoate

C21H21NO4 (351.14705060000006)


   

Methyl 2,2-dimethyl-5-(naphthalen-1-yliminomethyl)-4,6-dioxocyclohexane-1-carboxylate

Methyl 2,2-dimethyl-5-(naphthalen-1-yliminomethyl)-4,6-dioxocyclohexane-1-carboxylate

C21H21NO4 (351.14705060000006)


   

1-Benzyl-3,4-bis(methoxycarbonyl)-2-phenyl-3-pyrroline

1-Benzyl-3,4-bis(methoxycarbonyl)-2-phenyl-3-pyrroline

C21H21NO4 (351.14705060000006)


   

1-Methyl-2,5-diphenyl-2,5-dihydro-1H-pyrrole-3,4-dicarboxylic acid dimethyl ester

1-Methyl-2,5-diphenyl-2,5-dihydro-1H-pyrrole-3,4-dicarboxylic acid dimethyl ester

C21H21NO4 (351.14705060000006)


   

IMT1

IMT1

C21H21NO4 (351.14705060000006)


IMT1 is a first-in-class specific and noncompetitive human mitochondrial RNA polymerase (POLRMT) inhibitor. IMT1 causes a conformational change of POLRMT, which blocks substrate binding and transcription in a dose-dependent way in vitro. IMT1 reduces deoxynucleoside triphosphate levels and citric acid cycle intermediates, resulting in a marked depletion of cellular amino acid levels. IMT1 has the potential for mitochondrial transcription disorders related diseases[1].

   

(2-{14-methoxy-3,5,16-trioxapentacyclo[9.6.2.0²,⁶.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-1,6,8(18),9,11(19),12,14-heptaen-12-yl}ethyl)dimethylamine

(2-{14-methoxy-3,5,16-trioxapentacyclo[9.6.2.0²,⁶.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-1,6,8(18),9,11(19),12,14-heptaen-12-yl}ethyl)dimethylamine

C21H21NO4 (351.14705060000006)


   

14,15,16-trimethoxy-8,8-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,9(17),10,12,14-octaen-5-ol

14,15,16-trimethoxy-8,8-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,9(17),10,12,14-octaen-5-ol

C21H21NO4 (351.14705060000006)


   

1-[(12r,13r)-13-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]butan-1-one

1-[(12r,13r)-13-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]butan-1-one

C21H21NO4 (351.14705060000006)


   

3,4,11-trimethoxy-13-methyl-7,8-dihydro-6-azatetraphen-10-one

3,4,11-trimethoxy-13-methyl-7,8-dihydro-6-azatetraphen-10-one

C21H21NO4 (351.14705060000006)